Tools & Techniques Cancer

Cytotoxic Remediation

| Jonathan James

How a 3D-printed chemical absorber could pave the way for higher chemotherapy doses – or lower risks.

Tools & Techniques Imaging

FDISCO

| Jonathan James

A new tool in the pathologist’s arsenal may allow 3D imaging of tissues and organs.

Tools & Techniques Diagnostics & prognostics

IAs - ID'd

| Jonathan James

How the RNA transcriptome of circulating neutrophils could hold the key to identifying intracranial aneurysms – before they rupture.

Disease Area Infectious diseases

Managing Malaria with Smarter Sampling

| Jonathan James

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

Disease Area Neuroscience

Holding Back the Years

| Maryam Mahdi

Seeking inspiration from plants in the fight against Alzheimer’s disease.

Research Field Gene Editing

Dinner with a CRISPR Connoisseur

| Jonathan James

Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.

Outside the Lab Professional development

Revolutionizing Medicine – While Learning “Novartian”

| James Strachan

Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

Disease Area Infectious diseases

The Intersection of Infection and Biodefense

| Marcus Horwitz

Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.

Disease Area Infectious diseases

Fighting the Flu

| Jonathan James

A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza.

Tools & Techniques Imaging

Brain Bleeds Begone

| Jonathan James

A new approach may hold the key to preventing deadly brain bleeds - an optical lens capable of imaging blood vessels in real time.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register